D Brassat

Summary

Country: France

Publications

  1. pmc CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis
    Soraya Maria Menezes
    Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium
    J Neuroinflammation 11:18. 2014
  2. ncbi request reprint Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS
    D Brassat
    Department of Neurology, Hopital Purpan, Toulouse University Medical Center, Toulouse, France
    Neurology 59:954-5. 2002
  3. ncbi request reprint When does multiple sclerosis start? Three case reports and a review of the literature
    D Brassat
    Pôle des Neurosciences, INSERM U1043, Universite Toulouse III, CHU, Hopital Purpan, Place du Dr Baylac, Toulouse Cedex 9, France
    Rev Neurol (Paris) 168:846-51. 2012
  4. ncbi request reprint High-risk syndrome for neuromyelitis optica: a descriptive and comparative study
    N Collongues
    Department of Neurology, University Hospital of Strasbourg, 1 Place de l Hopital, Strasbourg, France
    Mult Scler 17:720-4. 2011
  5. ncbi request reprint Neuromyelitis optica and pregnancy
    B Bourre
    Department of Neurology, Hopital Charles Nicolle, Rouen, France
    Neurology 78:875-9. 2012
  6. ncbi request reprint Neuromyelitis optica in France: a multicenter study of 125 patients
    N Collongues
    Department of Neurology, University Hospital of Strasbourg, 67091 Strasbourg, France
    Neurology 74:736-42. 2010

Collaborators

Detail Information

Publications6

  1. pmc CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis
    Soraya Maria Menezes
    Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium
    J Neuroinflammation 11:18. 2014
    ..Although CD80 and CD86 costimulatory molecules play prominent roles in immune regulation and reflect disease status in multiple sclerosis (MS), data in HAM/TSP are lacking...
  2. ncbi request reprint Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS
    D Brassat
    Department of Neurology, Hopital Purpan, Toulouse University Medical Center, Toulouse, France
    Neurology 59:954-5. 2002
    ..Nevertheless, this case stresses the need to further evaluate the long-term risk of TRAL in patients with MS who receive mitoxantrone...
  3. ncbi request reprint When does multiple sclerosis start? Three case reports and a review of the literature
    D Brassat
    Pôle des Neurosciences, INSERM U1043, Universite Toulouse III, CHU, Hopital Purpan, Place du Dr Baylac, Toulouse Cedex 9, France
    Rev Neurol (Paris) 168:846-51. 2012
    ..Further criteria (McDonald) allowed even earlier diagnosis. In the present review, which also includes three case reports, the earliest possible timepoint for making the MS diagnosis is discussed...
  4. ncbi request reprint High-risk syndrome for neuromyelitis optica: a descriptive and comparative study
    N Collongues
    Department of Neurology, University Hospital of Strasbourg, 1 Place de l Hopital, Strasbourg, France
    Mult Scler 17:720-4. 2011
    ..Neuromyelitis optica (NMO) frequently begins with a monofocal episode of optic neuritis or myelitis. A concept named high-risk syndrome (HRS) for NMO has been proposed for patients with monofocal episodes and NMO-IgG antibodies...
  5. ncbi request reprint Neuromyelitis optica and pregnancy
    B Bourre
    Department of Neurology, Hopital Charles Nicolle, Rouen, France
    Neurology 78:875-9. 2012
    ..The purpose of our study was to assess the influence of pregnancy on the course of neuromyelitis optica (NMO) and the impact of epidural analgesia and breastfeeding on its activity in the postpartum period...
  6. ncbi request reprint Neuromyelitis optica in France: a multicenter study of 125 patients
    N Collongues
    Department of Neurology, University Hospital of Strasbourg, 67091 Strasbourg, France
    Neurology 74:736-42. 2010
    ..There have been few epidemiologic studies on neuromyelitis optica (NMO) and none used the recent 2006 diagnostic criteria. Here we describe the clinical, laboratory, MRI, and disability course of NMO in a French cohort of 125 patients...